# A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)

> **NCT01993979** · PHASE3 · UNKNOWN · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 261 (actual)

## Conditions studied

- Transitional Cell Carcinoma of Ureter

## Interventions

- **DRUG:** Chemotherapy
- **OTHER:** Surveillance

## Key facts

- **NCT ID:** NCT01993979
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2018-11-07
- **Final completion:** 2022-05
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2020-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01993979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01993979, "A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01993979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*